BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Di Marco M, Carloni R, De Lorenzo S, Mosconi C, Palloni A, Grassi E, Filippini DM, Ricci AD, Rizzo A, Di Federico A, Santini D, Turchetti D, Ricci C, Ingaldi C, Alberici L, Minni F, Golfieri R, Brandi G, Casadei R. Pancreatic mucinous cystadenocarcinoma in a patient harbouring BRCA1 germline mutation effectively treated with olaparib: A case report. World J Gastrointest Oncol 2020; 12(12): 1456-1463 [PMID: 33362915 DOI: 10.4251/wjgo.v12.i12.1456]
URL: https://www.wjgnet.com/1948-5204/full/v12/i12/1456.htm
Number Citing Articles
1
Taro Hanaoka, Kosuke Okuwaki, Kohei Nakamura, Shunji Okada, Nobuyuki Nishizawa, Masafumi Watanabe, Tomohisa Iwai, Kai Adachi, Yusuke Kumamoto, Chika Kusano. High likelihood of BRCA2 reversion mutation in pancreatic cancer post-platinum-based chemotherapy: a case studyInternational Cancer Conference Journal 2024;  doi: 10.1007/s13691-024-00715-0
2
Antineoplastics/folinic acidReactions Weekly 2021; 1842(1): 48 doi: 10.1007/s40278-021-90784-3
3
Luis Alberto Bravo-Vázquez, Natalia Frías-Reid, Ana Gabriela Ramos-Delgado, Sofía Madeline Osorio-Pérez, Hania Ruth Zlotnik-Chávez, Surajit Pathak, Antara Banerjee, Anindya Bandyopadhyay, Asim K. Duttaroy, Sujay Paul. MicroRNAs and long non-coding RNAs in pancreatic cancer: From epigenetics to potential clinical applicationsTranslational Oncology 2023; 27: 101579 doi: 10.1016/j.tranon.2022.101579